Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Novartis patent opposition analysis

Get Patent Opposition Report for Novartis

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Novartis

Explore patent oppositions filed by Novartis against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2784084Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHJul 24, 2019
EP2888626Contact Lens With A Hydrophilic LayerOCULAR DYNAMICSJan 18, 2019
EP2794727Ionic Silicone HydrogelsJOHNSON & JOHNSON VISION CAREOct 24, 2018
EP2705073Macroinitiator Containing Hydrophobic SegmentJOHNSON & JOHNSON VISION CAREOct 10, 2018
EP2855545Polymers And Nanogel Materials And Methods For Making And Using The SameJOHNSON & JOHNSON VISION CAREAug 1, 2018
EP1623269Hydrogel Contact Lenses And Package Systems And Production Methods For SameCOOPERVISIONFeb 9, 2018

Latest patents of Novartis opposed by its competitors

Explore Novartis's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3143995Jan 15, 2025A Rapamycin Derivative For Treating Lung Cancer21
EP3090730Jul 3, 2024Novel Pharmaceutical Composition14
EP2705808May 1, 2024Silicone Hydrogel Lenses With Water-Rich Surfaces1
EP3124018Apr 24, 2024Oral Formulations Of Deferasirox2
EP3529360Apr 17, 2024Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein Reduction5
EP3191120Apr 10, 2024Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis Patients3
EP3888674Apr 3, 2024Treatment Of Cancer Using Anti-Cd19 Chimeric Antigen Receptor1
EP4159204Feb 14, 2024Novel Pharmaceutical Composition4
EP4159205Feb 14, 2024Novel Pharmaceutical Composition5
EP3272764Feb 7, 2024Method For Affinity Chromatography1

Top competitors of Novartis